Management of iatrogenic XXXX .

@entity1 @entity1353 @entity397 @entity158 @entity204 @entity3526
BACKGROUND: To report our experience in the management of iatrogenic @entity3526 ( @entity3526 ). METHODS: During a 6-year period, 5 @entity1 were treated urgently for SAP. RESULTS: Two @entity1 presented with @entity397 , 2 with @entity1353 , whereas 1 had unremitting severe @entity158 . Three @entity1 underwent preoperative computed tomography angiography and 2 digital subtraction angiography. Three @entity1 were treated with an open surgical procedure, whereas 2 were managed by endovascular means. A combined supraclavicular and/or infraclavicular approach was used in 2 @entity1 , whereas a midsternotomy was mandatory to achieve proximal control in one. A combined transfemoral and/or brachial approach was used in both @entity1 treated endovascular. No perioperative @entity204 or procedure-related complications occurred. All symptoms were relieved, whereas the median hospital stay was 8 days. During a mean follow-up period of 20.4    10 months, none of the @entity1 needed any reintervention. CONCLUSIONS: Iatrogenic @entity3526 constitute a clinical entity that may need surgical treatment, especially in the presence of symptoms. In relatively stable @entity1 with no major compression issues, stenting could be considered as an adequate therapy for these situations. Open surgical repair should be considered when there is significant compression of adjacent structures or failure of the endovascular approach.
